Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PROTHENA CORP PUBLIC LTD CO Director's Dealing 2021

Apr 7, 2021

32782_dirs_2021-04-07_0922c84a-04d8-49df-b9de-27eebb9bc30a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PROTHENA CORP PUBLIC LTD CO (PRTA)
CIK: 0001559053
Period of Report: 2021-04-05

Reporting Person: Garren Hideki (Chief Medical Officer)

More from PROTHENA CORP PUBLIC LTD CO

Declaration of Voting Results & Voting Rights Announcements 2026
May 15
Proxy Solicitation & Information Statement 2026
Mar 27
Transaction in Own Shares 2026
Feb 27
Annual Report 2026
Feb 27
Earnings Release 2026
Feb 19
Board/Management Information 2025
Dec 12
Declaration of Voting Results & Voting Rights Announcements 2025
Nov 19
Major Shareholding Notification 2025
Nov 14
Major Shareholding Notification 2025
Nov 12
Major Shareholding Notification 2025
Nov 12
View all filings →